Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation

CMAJ. 2001 Aug 7;165(3):301-2.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alberta
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / drug therapy*
  • Attitude of Health Personnel*
  • Hemorrhage / chemically induced
  • Humans
  • Physicians / psychology*
  • Risk
  • Stroke / prevention & control
  • Warfarin / adverse effects
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Warfarin